Trial of antibody drug Trump touted as Covid-19 'cure' paused over safety concern

ReutersPublished: Oct 14, 2020 3:33 AM

US pharmaceutical company Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its Covid-19 antibody treatment similar to one taken by President Donald Trump was paused because of a safety concern.

Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his recent Covid-19 infection, as tantamount to a "cure" in a video he posted last week.

The announcement comes one day after Johnson & Johnson (J&J) said...

M'sia to be priority recipient of China-produced Covid-19 vaccine - Hishammuddin

China joins WHO-backed vaccine programme Covax rejected by Trump

Moderna Covid-19 vaccine appears safe, signs it works in older adults - study

M'sia to finalise Covid-19 vaccine selection by early 2021 - Khairy

Comments0

By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

Do's and don'ts when posting comments in Malaysiakini

TERMS & CONDITIONS

Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

REPORT VIOLATORS

Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

NOTICE

Our commenting system is still under development. We have taken note of feedback provided.

Subscriber-only space: